Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04961684Completed
Randomised, single-blind trial in onychomycosis (2 arms), sponsored by Oystershell. Primary endpoint: Percentage of healthy surface at 90 days. Started Feb 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04961684.